Key Pharmacovigilance Learnings from EMA PRAC June 2026 Meeting
Insights and Learnings from the June 2026 EMA PRAC Meeting Key Takeaways Increased focus on real-world data for pharmacovigilance assessments. Emphasis on the importance of timely reporting and data integrity. New guidelines on risk management plans and signal detection processes. Enhanced collaboration with stakeholders to improve patient safety. Recommendations for…